ISSN: 2161-1149 (Printed)
+44-77-2385-9429
Antirheumatic drugs are very commonly used to treat various forms of arthritis. These drugs are effective against the symptoms that occur in the arthritic disorders. They help the body to fight with the inflammation, pain and swelling that may have occurred on account of diseases. Innovations are new idea, device or process. Innovations are the application of better solutions that meet new requirements, inarticulated needs or existing market needs. It is proficient through more effective products, processes, services, technologies, or new ideas that are readily available to markets, governments and society.
antirheumatic drugs is a category of otherwise unrelated drugs defined by their use in rheumatoid arthritis to slow down disease progression. The term is often used in contrast to nonsteroidal anti-inflammatory drug (which refers to agents that treat the inflammation but not the underlying cause) and steroids (which blunt the immune response but are insufficient to slow down the progression of the disease).
The term "antirheumatic" can be used in similar contexts, but without making a claim about an effect on the course. Other terms that have historically been used to refer to the same group of drugs are "remission-inducing drugs" (RIDs) and "slow-acting anti-rheumatic drugs" (SAARDs).
Review Article: Rheumatology: Current Research
Research Article: Rheumatology: Current Research
Review Article: Rheumatology: Current Research
Editorial: Rheumatology: Current Research
Case Report: Rheumatology: Current Research
Scientific Tracks Abstracts: Virology & Mycology
Scientific Tracks Abstracts: Journal of Antivirals & Antiretrovirals
Scientific Tracks Abstracts: Journal of Antivirals & Antiretrovirals